Endogenous Endophthalmitis in Patients with MRSA Septicemia: A Case Series and Review of Literature

Shailaja Bhat Shenoy, Meena Thotakura, Yogish Kamath, Ragini Bekur

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Purpose: To report the presentation, predisposing factors, clinical features and outcome in 6 eyes of 3 patients with endogenous endophthalmitis secondary to methicillin resistant staphylococcus aureus (MRSA) septicaemia. Methods: Retrospective review of case records of 3 patients who were treated for endogenous endophthalmitis secondary to MRSA septicaemia in a tertiary referral institution. Results: All three patients had systemic predisposition to endogenous endophthalmitis (diabetes, urosepsis). Two patients presented within 1 week of onset of visual symptoms and the third after 3 months. Blood culture was positive for MRSA in all patients. Visual and anatomical improvement was noted in two patients who presented early. The third patient’s visual outcome despite early treatment with intravitreal antibiotics and vitrectomy was not satisfactory. Conclusion: Endogenous endophthalmitis by MRSA is a rare but serious condition. Early and specific therapy based on reliable detection of the underlying microorganism is needed for good anatomical and functional outcome.

Original languageEnglish
Pages (from-to)515-520
Number of pages6
JournalOcular Immunology and Inflammation
Volume24
Issue number5
DOIs
Publication statusPublished - 02-09-2016

Fingerprint

Endophthalmitis
Methicillin-Resistant Staphylococcus aureus
Sepsis
Vitrectomy
Secondary Prevention
Causality
Referral and Consultation
Anti-Bacterial Agents

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Ophthalmology

Cite this

@article{6ab6651fae0b40189cda4da6e0cc42d0,
title = "Endogenous Endophthalmitis in Patients with MRSA Septicemia: A Case Series and Review of Literature",
abstract = "Purpose: To report the presentation, predisposing factors, clinical features and outcome in 6 eyes of 3 patients with endogenous endophthalmitis secondary to methicillin resistant staphylococcus aureus (MRSA) septicaemia. Methods: Retrospective review of case records of 3 patients who were treated for endogenous endophthalmitis secondary to MRSA septicaemia in a tertiary referral institution. Results: All three patients had systemic predisposition to endogenous endophthalmitis (diabetes, urosepsis). Two patients presented within 1 week of onset of visual symptoms and the third after 3 months. Blood culture was positive for MRSA in all patients. Visual and anatomical improvement was noted in two patients who presented early. The third patient’s visual outcome despite early treatment with intravitreal antibiotics and vitrectomy was not satisfactory. Conclusion: Endogenous endophthalmitis by MRSA is a rare but serious condition. Early and specific therapy based on reliable detection of the underlying microorganism is needed for good anatomical and functional outcome.",
author = "Shenoy, {Shailaja Bhat} and Meena Thotakura and Yogish Kamath and Ragini Bekur",
year = "2016",
month = "9",
day = "2",
doi = "10.3109/09273948.2015.1020173",
language = "English",
volume = "24",
pages = "515--520",
journal = "Ocular Immunology and Inflammation",
issn = "0927-3948",
publisher = "Informa Healthcare",
number = "5",

}

Endogenous Endophthalmitis in Patients with MRSA Septicemia : A Case Series and Review of Literature. / Shenoy, Shailaja Bhat; Thotakura, Meena; Kamath, Yogish; Bekur, Ragini.

In: Ocular Immunology and Inflammation, Vol. 24, No. 5, 02.09.2016, p. 515-520.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Endogenous Endophthalmitis in Patients with MRSA Septicemia

T2 - A Case Series and Review of Literature

AU - Shenoy, Shailaja Bhat

AU - Thotakura, Meena

AU - Kamath, Yogish

AU - Bekur, Ragini

PY - 2016/9/2

Y1 - 2016/9/2

N2 - Purpose: To report the presentation, predisposing factors, clinical features and outcome in 6 eyes of 3 patients with endogenous endophthalmitis secondary to methicillin resistant staphylococcus aureus (MRSA) septicaemia. Methods: Retrospective review of case records of 3 patients who were treated for endogenous endophthalmitis secondary to MRSA septicaemia in a tertiary referral institution. Results: All three patients had systemic predisposition to endogenous endophthalmitis (diabetes, urosepsis). Two patients presented within 1 week of onset of visual symptoms and the third after 3 months. Blood culture was positive for MRSA in all patients. Visual and anatomical improvement was noted in two patients who presented early. The third patient’s visual outcome despite early treatment with intravitreal antibiotics and vitrectomy was not satisfactory. Conclusion: Endogenous endophthalmitis by MRSA is a rare but serious condition. Early and specific therapy based on reliable detection of the underlying microorganism is needed for good anatomical and functional outcome.

AB - Purpose: To report the presentation, predisposing factors, clinical features and outcome in 6 eyes of 3 patients with endogenous endophthalmitis secondary to methicillin resistant staphylococcus aureus (MRSA) septicaemia. Methods: Retrospective review of case records of 3 patients who were treated for endogenous endophthalmitis secondary to MRSA septicaemia in a tertiary referral institution. Results: All three patients had systemic predisposition to endogenous endophthalmitis (diabetes, urosepsis). Two patients presented within 1 week of onset of visual symptoms and the third after 3 months. Blood culture was positive for MRSA in all patients. Visual and anatomical improvement was noted in two patients who presented early. The third patient’s visual outcome despite early treatment with intravitreal antibiotics and vitrectomy was not satisfactory. Conclusion: Endogenous endophthalmitis by MRSA is a rare but serious condition. Early and specific therapy based on reliable detection of the underlying microorganism is needed for good anatomical and functional outcome.

UR - http://www.scopus.com/inward/record.url?scp=84939530770&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84939530770&partnerID=8YFLogxK

U2 - 10.3109/09273948.2015.1020173

DO - 10.3109/09273948.2015.1020173

M3 - Article

C2 - 26222985

AN - SCOPUS:84939530770

VL - 24

SP - 515

EP - 520

JO - Ocular Immunology and Inflammation

JF - Ocular Immunology and Inflammation

SN - 0927-3948

IS - 5

ER -